PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
news

Pharmaceutical industry needs more cross-sector collaboration

Connect in Pharma is promoting a new era of cross-sector collaboration within the pharmaceutical industry The newly announced agenda for Connect in Pharma sen...
Continue Reading →
Regional News

PCI Pharma Services Announces New Sterile Fill-Finish Capabilities Now Available in Melbourne and San Diego 

New equipment added to San Diego and Melbourne facilities will help with clinical scale and global capacity shortages PHILADELPHIA -April 18, 2023- PCI Pharm...
Continue Reading →
Regional News

With hard-fought Polivy approval, Roche looks to shake up decades of established practice in lymphoma

After a regulatory scare, Roche can now kick off work on changing nearly 20 years of clinical practice for the treatment of diffuse large B-cell lymphoma (DLBCL). ...
Continue Reading →
Regional News

Alnylam, Intra-Cellular among analyst’s top picks for M&A as biopharma dealmaking heats up

A series of acquisitions by GSK, Merck & Co. and Sanofi has analysts at RBC Capital Markets optimistic about the biopharma M&A landscape. And the team has so...
Continue Reading →
Regional News

GSK faces strike threat in UK, again, after workers pan pay raise

After skirting industrial action in 2022, GSK faces looming strikes across six of its sites in the United Kingdom next month, with hundreds of workers plotting walko...
Continue Reading →
Regional News

Newly merged manufacturers Meridian, Kindeva invest $100M in Missouri site

Five months after merging, manufacturers Kindeva Drug Delivery and Meridian Medical Technologies are expeanding their capabilities in Missouri. In a $100 million ...
Continue Reading →
Regional News

Takeda hit with another pay-for-delay lawsuit, this time on gout drug Colcrys

Takeda has already faced claims it used an illegal "pay-for-delay" deal to push back competition to constipation drug Amitiza. Now, a group of drug purchasers i...
Continue Reading →
Regional News

Astellas takes $340M charge on Evrenzo, joins GSK in nixing cell therapy collab with Adaptimmune

Astellas is doing some house cleaning under new CEO Naoki Okamura, writing off assets before its full-year earnings report. The Japanese pharma will take an impai...
Continue Reading →
Regional News

Moderna nabs a win in Arbutus patent case as appeals court upholds prior invalidation

While Arbutus Biopharma is busy scrapping with Moderna and Pfizer over COVID-19 vaccine patents, Moderna has chalked up a win in a separate case. Back i...
Continue Reading →
Regional News

Takeda gets FDA expansion of HyQvia to treat kids with primary immunodeficiency

Last month, Takeda revealed it was building a new manufacturing facility in Japan which would increase the company’s capacity for plasma production nearly fivefold i...
Continue Reading →
Quotient